Breast and Ovarian Cancer Genomics
1 – 10 of 94
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Dynamic assessment of proliferation to guide response-adapted therapy in the setting of neoadjuvant chemotherapy in ER+/HER2- breast cancer
- Contribution to journal › Article
- 2025
-
Mark
Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer—a Swedish gynecologic cancer group (Swe-GCG) study
- Contribution to journal › Article
-
Mark
Stand-alone transcriptional immune response prediction in primary triple-negative breast cancer
- Contribution to journal › Article
-
Mark
Navigating Immune Landscapes in Ovarian Cancer - Spatial and Genomic Insights into High-Grade Serous and Endometriosis-Associated Histotypes
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation
- Thesis › Doctoral thesis (compilation)
-
Mark
Primary treatment and survival in malignant ovarian germ cell tumors : A nationwide population-based Swedish Gynecologic Cancer Group (SweGCG) study
- Contribution to journal › Article
-
Mark
Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastases
- Contribution to journal › Article
-
Mark
Fusions4U: a resource of validated and annotated gene fusions in 328 cancer cell lines
(2025) In BMC Cancer
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma : anatomical site matters
- Contribution to journal › Article
-
Mark
Copy number signatures in cervical samples enable early detection of high-grade serous ovarian carcinoma
(2025) SCRM 2025 - the 7th Swedish Cancer Research Meeting
- Contribution to conference › Poster
-
Mark
The potential radiosensitization target PFKFB3 is related to response to radiotherapy in SweBCG91RT : a randomized clinical trial with long-term follow-up
- Contribution to journal › Article
